Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 1997

View Archived Issues

Lilly synthesizes antiobesity proteins

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Prokinetic agents from Tokyo Tanabe

Anti-HCV agents revealed by Japanese and Chinese investigators

Zeneca describes nonpeptide antagonists of NK2 receptors

Hoechst Japan describes immunosuppressive peptides

Allervax Cat moves towards commercialization

New form of DNA linked to prostate cancer

Neurobiological Technologies discontinues development of antiarthritic agent

Multikine enters clinical testing in AIDS patients

Draxis acquires Canadian rights to Mylan's paclitaxel formulation

Bimoclomol progresses in trials

Joint venture ends

Preclinical pharmacology profile of BMS NEP/ACE inhibitors described

Genzyme Transgenics, BASF forge agreement for transgenic production of biopharmaceuticals

Tri-Point seeks FDA approval for TraumaSeal

Roberts to market Lodine in U.K. and Ireland

Leptin triggers reproductive function

Caliper Technologies technology useful in drug discovery

Dexketoprofen trometamol: An NSAID with improved safety and efficacy

Celtrix completes phase I studies of SomatoKine

Pharmacyclics completes phase I testing of Lu-Tex

Immune Response announces results for rheumatoid arthritis Rx

Study results reported for Immune Response antipsoriatic agent

Oxis International completes phase I testing of IBD treatment

Digene seeks FDA marketing approval for cytomegalovirus test

Comparative clinical trials with Viracept

IAF BioVac vaccine R&D in review

BCH-4556 slated to enter clinical testing

Nasalcrom cleared by FDA as OTC

New analgesic drug candidate emerges from BioChem Pharma/Astra collaboration

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...